📖
Perianal fistulizing Crohn's disease increases infliximab clearance and causes low infliximab exposure (ATLANTIC).
Mulders LGM, Anjie SI, Chevallot-Beroux M, Loeff F, Wildenberg ME, Mathôt RAA, D'Haens GRAM, Gecse KB

Perianal fistulizing Crohn's disease increases infliximab clearance and causes low infliximab exposure (ATLANTIC).

Medicine & Health Verification Pending

Overview & Synopsis

Open access biomedical research article published in J Crohns Colitis.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Perianal fistulizing Crohn's disease increases infliximab clearance and causes low infliximab exposure (ATLANTIC).
Author / Organization Mulders LGM, Anjie SI, Chevallot-Beroux M, Loeff F, Wildenberg ME, Mathôt RAA, D'Haens GRAM, Gecse KB
Subject & Discipline J Crohns Colitis
Categories Medicine & Health
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-38909
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »